Old Web
English
Sign In
Acemap
>
authorDetail
>
Xuewen Ma
Xuewen Ma
Bristol-Myers Squibb
Pharmacology
Medicine
Antagonist
Physical therapy
Agonist
3
Papers
23
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
First‐in‐human study to assess the safety, pharmacokinetics and pharmacodynamics of BMS‐962212, a direct, reversible, small molecule factor XIa inhibitor in non‐Japanese and Japanese healthy subjects
2018
British Journal of Clinical Pharmacology
Vidya Perera
Joseph M. Luettgen
Zhaoqing Wang
Charles Frost
Cynthia Yones
Cesare Russo
John S. Lee
Yue Zhao
Frank LaCreta
Xuewen Ma
Robert M. Knabb
Dietmar A. Seiffert
Mary DeSouza
Pierre Mugnier
Brenda Cirincione
Takayo Ueno
Robert J.A. Frost
Show All
Source
Cite
Save
Citations (21)
Abstract TMP91: Phase I Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Oral Protease-activated Receptor-4 Antagonist BMS-986120
2016
Stroke
Fraz A. Ismat
Xuewen Ma
Zhaoqing Wang
Charles Frost
Yan G. Ni
Jing Yang
Show All
Source
Cite
Save
Citations (2)
Abstract WP263: Mutagenesis Studies Revealed Minimal Impact of Human A120T Variant of Protease-activated Receptor 4 on Receptor function or Pharmacological Response to a Potent and Selective Antagonist
2016
Stroke
Mario Callejo
Jeffrey Colin
Sophie Desmeules
Chi Sum
Tao Wang
John N. Feder
Gabe Mintier
Ke Xu
Zhaoqing Wang
Fraz A. Ismat
Xuewen Ma
Roger Rémillard
Jacques Banville
Anne Marinier
Scott Priestley
Michel Bouvier
Jing Yang
Show All
Source
Cite
Save
Citations (0)
1